Editd anti arrhythmic

ANTI-ARRHYTHMIC DRUGS Ma. Janetth B. Serrano, M.D.,DPBA

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

ELECTRO-PHYSIOLOGY OF NORMAL CARDIAC RHYTHM ,[object Object],AV node ATRIA His-Purkinje System VENTRICLES ANTI – ARRHYTHMIC DRUGS

IONIC BASIS OF MEMBRANE ELECTRICAL ACTIVITY ,[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

PHASES OF ACTION POTENTIAL ,[object Object],[object Object],[object Object],[object Object],Phase 1 >Limited depolarization >Inactivation of fast Na+ channels -> Na+ ion conc equalizes >↑ K+ efflux & Cl- influx Phase 2 >Plateau Stage >Cell less permeable to Na+ >Ca++ influx through slow Ca++ channels >K+ begins to leave cell Phase 3 >Rapid repolarization >Na+ gates closed >K+ efflux >Inactivation of slow Ca++ channels Phase 4 >Resting Membrane Potential >High K+ efflux >Ca++ influx ANTI – ARRHYTHMIC DRUGS

MECHANISMS OF ARRHYTHMIA ,[object Object],[object Object],ARRHYTHMIAS result from: ,[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

FACTORS PRECIPITATING CARDIAC ARRHYTHMIAS: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ARRHYTHMIAS: ANTI – ARRHYTHMIC DRUGS

CLASS I: Sodium Channel Blocking Drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS II: BETA-BLOCKING AGENTS ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS ANTI – ARRHYTHMIC DRUGS

CLASS IV: CALCIUM CHANNEL BLOCKERS ,[object Object],[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

Miscellaneous: ,[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: Sodium Channel Blocking Drugs CLASS IA: QUINIDINE ANTI – ARRHYTHMIC DRUGS

CLASS I: SODIUM CHANNEL BLOCKERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS IA: QUINIDINE ANTI – ARRHYTHMIC DRUGS

CLASS I: SODIUM CHANNEL BLOCKERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS IA: QUINIDINE ANTI – ARRHYTHMIC DRUGS

CLASS I: SODIUM CHANNEL BLOCKERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS IA: QUINIDINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: PROCAINAMIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: PROCAINAMIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: PROCAINAMIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: DISOPYRAMIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: AMIODARONE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: AMIODARONE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IA: AMIODARONE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IB: LIDOCAINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IB: LIDOCAINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IB: LIDOCAINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IB: TOCAINIDE & MEXILETENE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IB: PHENYTOIN ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IC: FLECAINIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IC: PROPAFENONE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS I: SODIUM CHANNEL BLOCKERS CLASS IC: MORICIZINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS II: BETA ADRENOCEPTOR BLOCKERS ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS II: BETA ADRENOCEPTOR BLOCKERS ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],CLASS II: BETA ADRENOCEPTOR BLOCKERS Specific agents: ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS BRETYLIUM ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS BRETYLIUM ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS SOTALOL ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS IBUTILIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS III: POTASSIUM CHANNEL BLOCKERS DOFETILIDE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],CLASS IV: CALCIUM CHANNEL BLOCKERS VERAPAMIL ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],CLASS IV: CALCIUM CHANNEL BLOCKERS VERAPAMIL ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],CLASS IV: CALCIUM CHANNEL BLOCKERS DILTIAZEM & BEPRIDIL ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],MISCELLANEOUS ANTIARRHYTHMIC AGENTS: DIGITALIS ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],MISCELLANEOUS ANTIARRHYTHMIC AGENTS: ADENOSINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],MISCELLANEOUS ANTIARRHYTHMIC AGENTS: ADENOSINE ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],MISCELLANEOUS ANTIARRHYTHMIC AGENTS: MAGNESIUM ANTI – ARRHYTHMIC DRUGS

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ANTI – ARRHYTHMIC DRUGS MISCELLANEOUS ANTIARRHYTHMIC AGENTS: POTASSIUM

Editd anti arrhythmic

Recommandé

Recommandé

Contenu connexe

Tendances

Tendances (19)

En vedette

En vedette (6)

Similaire à Editd anti arrhythmic

Similaire à Editd anti arrhythmic (20)

Plus de MD Specialclass

Plus de MD Specialclass (20)

Dernier

Dernier (20)

Editd anti arrhythmic

Notes de l'éditeur